EPAM Systems reported third-quarter results that exceeded revenue and adjusted EPS expectations, driven by 12% year-over-year organic growth in digital engineering and cloud services. The company generated a record $420 million in operating cash flow, up 18% sequentially, reflecting tight working-capital discipline. Management raised full-year guidance for revenues by $100 million and for operating margin by 50 basis points, citing robust demand for AI-native engineering solutions across financial services, life sciences, and retail verticals. Despite these positives, the shares have rallied over 30% since the Q3 release, creating valuation risk relative to services peers trading at 14–16x forward EBITDA, while EPAM commands a 20x multiple.

CEO Balazs Fejes highlighted EPAM’s shift to an AI-first delivery model, integrating proprietary platforms such as EPAM AI/RUN™ and in-house GenAI research from DIALX Lab. The strategy leverages 55,000 engineers across 40 delivery centers to accelerate client innovation cycles. Large financial institutions accounted for 27% of Q3 revenues, with technology and healthcare each contributing roughly 20%. This diversification has insulated growth from sector-specific slowdowns but requires continued investment in upskilling and cloud partnerships to maintain differentiated capabilities.

Despite the guidance bump, Q3 operating margin contracted by 60 basis points sequentially to 17.8%, driven by elevated recruiting costs and a temporary utilization dip to 80.5%. Management forecasts a gradual improvement to 18.5% by year-end as bench levels normalize, but warns of ongoing inflationary pressure on salaries in Eastern Europe and Asia. Investors should watch utilization trends and project ramp-downs in banking deals, which together could erode near-term profitability if demand softens in H1 2026.

EPAM will host an Investor Day on March 12, 2026 in Boston, featuring presentations by Fejes and CFO Jason Peterson. The agenda includes detailed case studies on AI-enabled digital transformations for global enterprises, client testimonials, and live demonstrations of GenAI applications. The company aims to articulate its path to $6 billion in revenues by 2027 with mid-teens operating margins, supported by new industry partnerships and expanded consulting capabilities under the EPAM Continuum brand. In-person attendance is by invitation only, with a live webcast to follow on the investor relations website.